Clinical Trial Update: Sequential Radiotherapy With CAR-T Cells in the Treatment of Relapsed and Refractory Hematological Malignancies With Extramedullary Lesions [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating sequential radiotherapy combined with CAR-T cells for relapsed/refractory hematological malignancies with extramedullary lesions; cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematological Malignancies

Snippet

Sponsor: Zhejiang University | Conditions: Hematological Malignancies | Phase 1, Phase 2 | Status: UNKNOWN